The U.S. Department of Commerce’s National Institute of Standards and Technology (NIST) has made two awards totaling $153 million to the National Institute for Innovation in Manufacturing Biopharmaceuticals (NIIMBL). The awards were announced today by U.S. Secretary of Commerce Gina Raimondo at the NIIMBL annual meeting in Washington, D.C.

NIIMBL...

We are proud to share the NIIMBL technology roadmaps with the biopharmaceutical manufacturing community. These documents identify the manufacturing needs and propose a vision of the future for three key topics areas: Vaccines, Antibody-Drug Conjugates and Bi-specific Antibodies, and Gene Therapies.

The Institute convened subject matter experts from...